Identification of <i>Candida parapsilosis</i> <i>sensu lato</i> and antifungal susceptibility testing of candidemia patients in a tertiary-care hospital in Malaysia.

ABSTRACT: Candidemia is the fourth most common nosocomial bloodstream infection and the most prevalent nosocomial fungal infection. Candida parapsilosis complex is the second most frequently identified species from blood samples in different countries worldwide, exceeding the prevalence of Candida albicans in some hospitals. Proper conventional identification of C. parapsilosis to subspecies level and confirming this identification using molecular methods such as amplifying and sequencing the internal transcribed spacer-polymerase chain reaction (ITS-PCR) help promptly in final diagnosis of candidemia. In addition, antifungal susceptibility testing (AFST) is becoming mandatory for each individualized sample; a reliable estimation of antifungal susceptibility of Candida ca

SUBMITTER: Yamin D 

PROVIDER: S-EPMC12772269 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature